TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07702292: A Phase 2 Study of [68Ga]BED003 for PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Sponsor: Blue Earth Diagnostics · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 71 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$11,642,400

Rescue Site Savings

+$7,669,200

Unlock Full NCT07702292 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07702292 Rescue Dossier →